3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Barrett Esophagus
15
Esophageal Neoplasms
10
Colorectal Neoplasms
10
Rectal Neoplasms
7
Adenocarcinoma Of Esophagus
7
Stomach Neoplasms
6
Colonic Neoplasms
5
Gastroesophageal Reflux
4
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Precancerous Conditions
2
Pathologic Complete Response
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Adenomatous Polyposis Coli
2
Adenocarcinoma
2
Stomach Ulcer
1
Stomach Diseases
1
Recurrence
1
Polyps
1
Polyposis, Gastric
1
Pancreatic Pseudocyst
1
Neoplasms
1
Metaplasia
1
Locally Advanced Pancreatic Cancer
1
Hyperplasia
1
Gastroparesis
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Gastric Outlet Obstruction
1
Fistula
1
Interventions
pembrolizumab
1
camrelizumab
1
apatinib
1
Surgical Procedures, Operative
1
Ocoxin
1
Hyperthermic Intraperitoneal Chemotherapy
1
Everolimus
1
Endoscopy
1
Capecitabine
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Stomach Diseases
×
Endoscopy
×
Gastrointestinal
×
Clear all
NCT02219529
2015-07-21
MCE
Changhai Hospital
Phase 3
Completed
350 enrolled